Bernhard Hampl
Advisory Board
Formycon
Germany
Biography
Over the past 20 years, Dr. Bernhard Hampl, who has a doctorate in the field of pharmaceutical chemistry, was a successful CEO in large American generics companies such as EON LABS Inc. and later Sandoz US, which after fusion of the two companies became America’s second-largest manufacturer of generics. Dr. Hampl, who started his career at the German subsidiary of American Cyanamid / Lederle in Wolfratshausen near Munich, has been living in Connecticut/USA for the past 20 years and brings wide-ranging international experience to Formycon. Today, he advises companies from the field of pharmaceuticals and biotechnology as well as investment companies.
Research Interest
Pharmaceutical Chemistry
